Ifat Sarouk

728 total citations
31 papers, 384 citations indexed

About

Ifat Sarouk is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Neurology. According to data from OpenAlex, Ifat Sarouk has authored 31 papers receiving a total of 384 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Pulmonary and Respiratory Medicine, 5 papers in Molecular Biology and 3 papers in Neurology. Recurrent topics in Ifat Sarouk's work include Cystic Fibrosis Research Advances (16 papers), Neonatal Respiratory Health Research (7 papers) and Tracheal and airway disorders (6 papers). Ifat Sarouk is often cited by papers focused on Cystic Fibrosis Research Advances (16 papers), Neonatal Respiratory Health Research (7 papers) and Tracheal and airway disorders (6 papers). Ifat Sarouk collaborates with scholars based in Israel, Belgium and Czechia. Ifat Sarouk's co-authors include Ori Efrati, Daphna Vilozni, Avishay Lahad, Andreea Nissenkorn, Dalit Modan‐Moses, Adi Dagan, K. De Boeck, Yael Levy‐Shraga, F. Vermeulen and Anabela S. Ramalho and has published in prestigious journals such as American Journal of Respiratory and Critical Care Medicine, European Respiratory Journal and Developmental Medicine & Child Neurology.

In The Last Decade

Ifat Sarouk

29 papers receiving 381 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ifat Sarouk Israel 11 215 122 56 42 34 31 384
Michael Infeld United States 7 169 0.8× 65 0.5× 23 0.4× 135 3.2× 14 0.4× 13 366
Jullet Han United States 7 54 0.3× 150 1.2× 23 0.4× 14 0.3× 17 0.5× 16 303
Sheeba Mathew United States 7 90 0.4× 144 1.2× 22 0.4× 106 2.5× 29 0.9× 8 373
Eirini Apostolou Greece 9 55 0.3× 92 0.8× 10 0.2× 27 0.6× 16 0.5× 22 289
David Curran Ireland 8 137 0.6× 60 0.5× 46 0.8× 113 2.7× 6 0.2× 23 326
Alecia‐Jane Twigger Australia 10 120 0.6× 177 1.5× 63 1.1× 18 0.4× 73 2.1× 14 537
Laura Dunn United States 6 59 0.3× 57 0.5× 23 0.4× 22 0.5× 30 0.9× 8 318
Naohiro Kanayama Japan 8 55 0.3× 63 0.5× 35 0.6× 19 0.5× 60 1.8× 12 369
Clara Franco‐Jarava Spain 10 38 0.2× 54 0.4× 31 0.6× 31 0.7× 66 1.9× 33 352
Aleksandra Szczawińska-Popłonyk Poland 11 51 0.2× 72 0.6× 12 0.2× 28 0.7× 95 2.8× 47 343

Countries citing papers authored by Ifat Sarouk

Since Specialization
Citations

This map shows the geographic impact of Ifat Sarouk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ifat Sarouk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ifat Sarouk more than expected).

Fields of papers citing papers by Ifat Sarouk

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ifat Sarouk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ifat Sarouk. The network helps show where Ifat Sarouk may publish in the future.

Co-authorship network of co-authors of Ifat Sarouk

This figure shows the co-authorship network connecting the top 25 collaborators of Ifat Sarouk. A scholar is included among the top collaborators of Ifat Sarouk based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ifat Sarouk. Ifat Sarouk is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Marcu‐Malina, Victoria, Ifat Sarouk, Amilia Meir, et al.. (2024). Genotoxicity Associated with Retroviral CAR Transduction of ATM -Deficient T Cells. Blood Cancer Discovery. 5(4). 267–275. 1 indexed citations
2.
Sarouk, Ifat, Hanoch Senderowitz, Malena Cohen‐Cymberknoh, et al.. (2020). Phenotypic and molecular characteristics of CF patients carrying the I1234V mutation. Respiratory Medicine. 170. 106027–106027. 3 indexed citations
3.
Vilozni, Daphna, et al.. (2020). Advanced Lung Disease in Patients with Cystic Fibrosis Is Associated with Low Diffusion capacity.. PubMed. 22(12). 770–774.
4.
Ramalho, Anabela S., Annelotte M. Vonk, Marc Ferrante, et al.. (2020). Correction of CFTR function in intestinal organoids to guide treatment of cystic fibrosis. European Respiratory Journal. 57(1). 1902426–1902426. 79 indexed citations
5.
Sarouk, Ifat, et al.. (2018). Omalizumab in allergic bronchopulmonary aspergillosis in patients with cystic fibrosis. Journal of Asthma and Allergy. Volume 11. 101–107. 27 indexed citations
6.
Nissenkorn, Andreea, Tomer Erlich, Dorit E. Zilberman, et al.. (2018). Secondary enuresis and urological manifestations in children with ataxia telangiectasia. European Journal of Paediatric Neurology. 22(6). 1118–1123. 1 indexed citations
7.
Lahad, Avishay, Lior Goldberg, Ifat Sarouk, et al.. (2018). Elevated IgM levels as a marker for a unique phenotype in patients with Ataxia telangiectasia. BMC Pediatrics. 18(1). 185–185. 15 indexed citations
8.
Vilozni, Daphna, et al.. (2018). The Value of Measuring Inspiratory Capacity in Subjects With Cystic Fibrosis. Respiratory Care. 63(8). 981–987. 2 indexed citations
9.
Dagan, Adi, Malena Cohen‐Cymberknoh, Michal Shteinberg, et al.. (2017). Ivacaftor for the p.Ser549Arg (S549R) gating mutation – The Israeli experience. Respiratory Medicine. 131. 225–228. 21 indexed citations
10.
Vilozni, Daphna, et al.. (2016). Consequences of Expiratory Flow Limitation at Rest in Subjects with Cystic Fibrosis. Annals of the American Thoracic Society. 13(6). 825–832. 4 indexed citations
11.
Nissenkorn, Andreea, et al.. (2016). Endocrine abnormalities in ataxia telangiectasia: findings from a national cohort. Pediatric Research. 79(6). 889–894. 55 indexed citations
12.
Vilozni, Daphna, et al.. (2015). Cough ability measurements and recurrent respiratory symptoms in individuals with Ataxia Telangiectasia. Journal of Asthma. 53(1). 37–42. 3 indexed citations
13.
Vilozni, Daphna, et al.. (2015). FVC deterioration, airway obstruction determination, and life span in Ataxia telangiectasia. Respiratory Medicine. 109(7). 890–896. 3 indexed citations
14.
Laitman, Yael, Michal Berkenstadt, Daphna Weissglas‐Volkov, et al.. (2015). The risk for developing cancer in Israeli ATM, BLM, and FANCC heterozygous mutation carriers. Cancer Genetics. 209(3). 70–74. 24 indexed citations
15.
Vilozni, Daphna, Ifat Sarouk, Hannah Kanety, et al.. (2015). Glucose intolerance in cystic fibrosis as a determinant of pulmonary function and clinical status. Diabetes Research and Clinical Practice. 110(3). 276–284. 24 indexed citations
16.
17.
Gayer, Gabriela, et al.. (2015). Tracheal diverticula in cystic fibrosis—A potentially important underreported finding on chest CT. Journal of Cystic Fibrosis. 15(4). 503–509. 6 indexed citations
18.
Vilozni, Daphna, et al.. (2014). Late-breaking abstract: The Effect of lung volume deterioration on tidal volume, airway flows and life span in ataxia telangiectasia. European Respiratory Journal. 44(Suppl 58). P4518–P4518. 1 indexed citations
19.
Sarouk, Ifat, et al.. (2014). Several siblings with Cystic Fibrosis as a risk factor for poor outcome. Respiratory Medicine. 109(1). 74–78. 5 indexed citations
20.
Vilozni, Daphna, et al.. (2012). Progressive Flow-to-Volume Dysanapsis in Cystic Fibrosis: A Predictor for Lung Transplantation?. American Journal of Respiratory and Critical Care Medicine. 186(1). 82–87. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Michael Infeld Breakdown of academic impact, for papers by Jullet Han Breakdown of academic impact, for papers by Sheeba Mathew Breakdown of academic impact, for papers by Eirini Apostolou Breakdown of academic impact, for papers by David Curran Breakdown of academic impact, for papers by Alecia‐Jane Twigger Breakdown of academic impact, for papers by Laura Dunn Breakdown of academic impact, for papers by Naohiro Kanayama Breakdown of academic impact, for papers by Clara Franco‐Jarava Breakdown of academic impact, for papers by Aleksandra Szczawińska-Popłonyk
Rankless by CCL
2026